Nicotinamide adenine dinucleotide, a coenzyme critical for cellular energy metabolism that declines with age. NAD+ precursors like NMN and NR are studied as longevity interventions.

Mechanistic target of rapamycin, a key nutrient-sensing pathway that regulates cell growth and aging. Inhibiting mTOR (e.g., with rapamycin) has shown lifespan extension in multiple organisms.

A class of drugs that selectively eliminate senescent (aged, dysfunctional) cells to reduce inflammation and improve tissue function.

What is Epigenetic clock?

A biomarker based on DNA methylation patterns that estimates biological age, often more predictive of health outcomes than chronological age.

The period of life spent in good health, free from chronic diseases and disability associated with aging.

An immunosuppressant drug that inhibits the mTOR pathway. Research shows rapamycin may extend lifespan and improve age-related health outcomes in multiple species.

What is Biological age?

A measure of how well or poorly your body is functioning relative to your chronological age, assessed through biomarkers such as DNA methylation, telomere length, and blood panels.

What is Caloric restriction?

A dietary regimen that reduces calorie intake without malnutrition. Caloric restriction is one of the most studied interventions shown to extend lifespan across species.

Protective caps at the ends of chromosomes that shorten with each cell division. Telomere length is associated with aging and age-related diseases.

A state in which cells permanently stop dividing but resist death, accumulating with age and secreting inflammatory factors that damage surrounding tissue.

A second-generation epigenetic clock that predicts time to death and is considered one of the most accurate measures of biological aging.

What is Inflammaging?

Chronic, low-grade inflammation that increases with age and contributes to the development of age-related diseases including cardiovascular disease, diabetes, and neurodegeneration.

The large-scale study of proteins in biological systems. In longevity research, proteomics identifies blood protein signatures that predict biological age and disease risk.

What is Yamanaka factors?

A set of four transcription factors (Oct4, Sox2, Klf4, c-Myc) that can reprogram adult cells to a pluripotent state. Partial reprogramming with Yamanaka factors is being explored to reverse cellular aging.

Nicotinamide mononucleotide, a precursor to NAD+ that is widely studied as a supplement to boost cellular energy and combat age-related decline.

A gene-editing technology that allows precise modifications to DNA. In longevity research, CRISPR is used to study and potentially modify genes associated with aging.

NEW YORK PLASTIC SURGICAL GROUP ANNOUNCES OPENING OF HARRISON, NY LOCATION

New York Plastic Surgical Group (NYPS Group) has expanded its footprint with the opening of a new office in Harrison, NY, marking its 13th location in the New York area. This strategic move enhances patient access to a network of award-winning surgeons specializing in a comprehensive range of cosmetic and reconstructive services, including breast, body, and facial aesthetics, as well as microsurgery and trauma reconstruction. The new facility spans 3,500 square feet and will facilitate consultations and in-office procedures, while surgeries will be performed at affiliated hospitals such as White Plains Hospital and Greenwich Hospital - Yale New Haven Health.

The significance of this expansion lies in NYPS Group’s commitment to delivering world-class surgical care and addressing the growing demand for advanced aesthetic and reconstructive treatments in the Westchester community. With a legacy dating back to 1948 and a track record of treating over half a million patients, NYPS Group is recognized for its expertise in patient safety and natural-looking results. The practice’s surgeons have received numerous accolades, including being the top provider of Allergan products in New York State and ranking among the top 1% of providers nationwide.

This expansion not only reflects NYPS Group’s dedication to sustainable growth but also underscores a shift in how plastic surgery practices can enhance patient access to specialized care. As the field continues to evolve, such expansions may influence future trends in patient-centered care models and the integration of advanced technologies in surgical practices, potentially accelerating timelines for innovative treatment options in the cosmetic and reconstructive domains.

Source: globenewswire.com